Carruthers R Michael 4
4 · Edgewise Therapeutics, Inc. · Filed Oct 16, 2024
Insider Transaction Report
Form 4
Carruthers R Michael
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-10-11−70,000→ 127,122 totalExercise: $0.71From: 2024-09-01Exp: 2030-09-01→ Common Stock (70,000 underlying) - Exercise/Conversion
Common Stock
2024-10-11$0.71/sh+70,000$49,700→ 76,904 total